Sergey Badalyan, Publishing Editor at OncoDaily and Medical Oncology Resident at Yeolyan Hematology and Oncology Center, shared a post on LinkedIn:
“Official Opening Ceremony | ESMO 2025
Berlin Auditorium (HUB 27)
This year marks a record-breaking participation at hashtag#ESMO25, over 35,000 oncology professionals from across the globe, reflecting the unstoppable momentum of cancer research and collaboration.
By the numbers:
- 5,677 abstracts submitted – double compared to 2016!
- 2,926 abstracts selected for presentation
- 3 Presidential Symposia
- 12 presentations with dedicated discussants
- 264 experts serving on the Scientific Committee
New scientific tracks unveiled this year:
1. Tumour Agnostic
2. AI and Digital Health
3. Prevention, Early Detection, and Intervention
Cross-cutting themes shaping the future of oncology:
- Antibody Drug Conjugates (ADCs): Can they cure early-stage cancer?
- Circulating Tumour DNA (ctDNA): Can we select patients for systemic therapy through liquid biopsy?
- Radioligand Therapies (RLT): What’s new – and how early can they be used in the disease course?
- Novel Cellular Therapies: Are we finally ready for prime time?
Opportunities in Rare Cancers
The atmosphere at HUB 27 is electric, filled with inspiration, discovery, and the shared mission of advancing cancer care.
Berlin is ready. Oncology is evolving. The future starts here.”
You Can Also Read:
An ultimate guide for the ESMO 2025: How to best prepare for Berlin?
